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Prevalence Of Constipation In Patients With Advanced Kidney Disease
Abstract
Background: For people on peritoneal dialysis (PD), constipation is associated with technique failure. For
those on haemodialysis (HD), constipation has been associated with a reduction in quality of life.
Objectives: The objectives of this study were to (i) determine the prevalence of functional constipation; (ii)
compare patient perception of constipation with Rome III criteria for functional constipation; (iii) describe
the prevalence of constipation and stool form using Bristol Stool Form Scale (BSFS); (iv) determine
differences in bowel habit and stool form between those on dialysis compared to pre-dialysis; and (v)
determine the diagnostic accuracy of self-perception and the Rome III criteria against the BSFS. A crosssectional group of pre-dialysis (eGFR < 15 ml/min) and dialysis patients were recruited. A total of 148
patients participated (98 HD, 21 PD and 21 pre-dialysis). Participants: Completed a questionnaire
consisting of self-perception of the presence of constipation, simplified questions from the Rome III
criteria for functional constipation, scored their stool form using the BSFS and reported laxative use.
Results: The prevalence of constipation using the Rome III criteria was 12.3%; patient perception 46.3%
and 25.7% using the BSFS. Prevalence differed according to the tool used. Conclusion: No single method
alone is sufficient for accurately determining if a patient is constipated. Relying on patients' selfperception may be unreliable. Ideally patient assessment of constipation should incorporate both the
Rome III criteria and BSFS in a method such as the one designed as a result of this research. Further
research is needed to assess its usability and practicality in clinical practice.
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Introduction
Constipation is a common medical condition associated with increased healthcare costs and
impaired quality of life. There are numerous factors that contribute to constipation such as
low fibre diet and low fluid intake, poor or low levels of mobility, lack of exercise, anxiety,
depression, chronic medical conditions such as diabetes, medications such as opioids and
increasing age. (Huether, 2006; Digestive Health Foundation, 2007; Johanson & Kralstein,
2007; JBI 2008; Selby & Corte,2010; Lee, 2011 Markland & Burgio,2013).
For people with Chronic Kidney Disease (CKD) constipation can be problematic especially for
those on dialysis. In this patient group, constipation is compounded by diet and fluid
restrictions, physical inactivity and medications such as phosphate binders and resins which
all add to the problem (Adams, 1982; Chambers, 1983; Stone, 1977; Yasuda et al, 1995;
Hung et al, 2007, JBI 2015).
For people on peritoneal dialysis (PD), constipation is associated with technique failure either
due to peritoneal catheter migration, malfunction or peritonitis (Gokal et al, 1998, Li et al,
2010,Sutton et al 2014). In people on haemodialysis (HD) constipation has been associated
with a reduction in quality of life and as a contributing factor to malnutrition (Hung et al 2007;
Nakabayashi et al 2011). People on HD have a higher prevalence of and more severe
constipation compared to those on PD (Zhang et al 2013; Dong et al 2014).The reasons for
this remain unexplored. It may be possible that because constipation does not directly
interfere with the HD procedure, it may be poorly reported.
The reliance on self reporting is difficult when diagnosing constipation, as people’s perception
may not accurately indicate the actual problem (Lee, 2011). This is a major negative aspect
of research as people’s perception of constipation or altered bowel function is not clearly
defined nor are assessment tools consistently utilised. In some studies the use of
assessment tools have found that the rate of constipation is considerably higher when based
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on self reported definitions probably due to personal perception rather than the actual
problem (Lee, 2011)

The Bristol Stool Form Scale (BSFS) and the Rome criteria are two validated methods that
can be used to assess constipation. The BSFS describes stool form using seven (7)
categories, with images as well as written descriptions (Lewis & Heaton 1997.)The Rome
criteria (Garrigues et al., 2004; Pappas et al., 2008; Rome Foundation, 2010; Selby & Corte,
2010) are used to diagnose constipation and other bowel disorders. Constipation must
include at least 2 of the following criteria, less than 3 defecations per week, straining during
defecation, hard or lumpy stools, sensation of incomplete evacuation, manual manoeuvre to
facilitate defecation or sensation of anal blockage during defecation. It can therefore be used
as a clinical tool to define and identify functional and / or chronic constipation. The version
used in this study is the Rome III. There are many causes of constipation but for the purpose
of this study only functional constipation was assessed; that is constipation that has no
underlying disease (Pare & Fedorak 2014)
Utilising a group of patients with CKD, the objectives of this study were to
1. determine the prevalence of functional constipation (as per Rome III criteria)
2. compare patient perception of constipation with Rome III criteria for functional
constipation
3. describe the prevalence of constipation and stool form using BSFS
4. determine if there are differences in bowel habit and stool form between those on dialysis
compared to pre dialysis
5. determine the diagnostic accuracy of self perception and the Rome III criteria against the
BSFS
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Methods
A cross sectional group of pre dialysis (eGFR < 15 ml/min) and dialysis patients were
recruited from a large regional health service. Exclusion criteria included those patients under
the care of a nephrologist with an eGFR ≤15 mLs/min and opting for conservative
management; those undertaking dialysis for less than three months; kidney transplant
recipients; patients with a colostomy or ileostomy and those with inadequate English
language skills to complete a written questionnaire.

Potential participants were approached and verbally informed of the project by either the
principle investigator or a co investigator at a time of attending the renal service either for
haemodialysis or a medical/nursing clinical appointment. A participant information sheet was
provided and potential participants were encouraged to read the information and discuss the
project with family or a carer. Participants were not required to attend outside their normal
dialysis hours or follow up visit appointment minimising any inconvenience to them. Written
consent was obtained from each participant.

Participants were asked to complete a questionnaire about their bowel habits. This consisted
of a simple version of the questions contained in the Rome III criteria for diagnosis of
functional constipation questions relating to self perception of the presence of constipation
(Appendix 1) and scoring of their stool using the BSFS
(http://upload.wikimedia.org/wikipedia/commons/b/b4/Bristol_Stool_Chart.p)
Participants were also asked to document any laxatives or aperient used. Basic demographic
data regarding age, duration of renal replacement therapy was recorded. Research Ethics
approval was granted for this project from the relevant committee.
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Statistical analysis was performed using SPSS Statistics for Windows version 21(SPSS,
Chicago, IL, USA). Normality was assessed using the Shapiro Wilk test. Differences between
groups or in the proportions between groups were evaluated using either the ANOVA or Chi
Square tests. Pearson’s correlation was used to investigate the relationship between relevant
variables and the presence of constipation. Sensitivity and specificity values were calculated
to determine agreement between the presence of constipation (evaluated using the BSFS as
the gold standard) and relavant variables. The kappa coeffient and receive operator
characteristic curves were calculated to determine the agreement and diagnostic accuracy of
relevant variables compared to the BSFS. AUC values of <0.7 (poor test); 0.7-09 (fair to good
test) and >0.9 (Excellent test) were used. A p value of <0.05 was considered significant for
all analyses. Results were also interpreted for clinical importance, that is, were the results
meaningful and of practical importance to clinicians.

RESULTS
A total of 157 individuals were approached to participate in the study. One hundred and forty
(89%) agreed to participate. The groups consisted of 98 haemodialysis patients, 21
peritoneal dialysis patients and 21 pre dialysis patients. There were no significant differences
between the three groups for age, sex or proportion of patients with diabetes. Mean dialysis
vintage was longer in the HD group 8.45 years compared to 5.32 years in the PD group
(table 1, p= 0.001). Diabetic nephropathy was the primary cause of renal failure in both the
HD group and pre dialysis group, whereas in the PD group diabetic nephropathy and
hypertension were equally reported. Demographic and clinical profile can be seen in tables 1
and 2. There was no statistical difference between groups in laxative use (table 1, p=0.39).
The most common types of laxatives used are seen in table 3 and overall the use of these
was low.
5

Prevalence of constipation
Constipation was present in all three groups, however the prevalence of constipation differed
according to the method used to measure constipation (Table 4). The prevalence of
constipation using the Rome III criteria was 12.3%; patient perception 46.3% and 25.7%
using the BSFS. There were also variations in which group had the highest prevalence
according to the tool used. PD patients had the highest prevalence of constipation using the
Rome III criteria; pre dialysis patients had highest prevalence using self-perception and HD
patients had highest prevalence of constipation using the BSFS.

Diagnostic accuracy of tools to assess constipation
For the purposes of this analysis, the BSFS was considered the gold standard for diagnosis
of constipation. This is because the tool is easy to administer, reliable and commonly
available in our health service for nursing staff to use. In this study, the most sensitive
methods for detecting those most likely to be constipated were questions 3 and 4 of the
Rome III criteria; then Rome III total score (see table 5). The method with the greatest
specificity was question 2 (asking how often have hard/lumpy stools in last 3 months). The
kappa value scores for agreement between the BSFS and most variables were all in the poor
to fair agreement range (0.17-0.33) and only one was statistically significant (question 3 and
4 combined). When not using the BSFS, then the next best diagnostic test for constipation
would be completion of the total Rome III score; followed by question 4. These are both good
to excellent tests as evidenced by the good to excellent AUC scores (AUC values of 0.88 and
0.81 respectively) (table 5).
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Factors associated with constipation
A number of factors (table 6) were strongly associated with constipation using the Rome III
criteria. These included question 3 of the Rome criteria (straining during bowel movement)
(r= 0.9, p<0.0001).Other factors strongly associated with total Rome III score included
question 6 (how often in last 3 months had sensation of stool that could not be passed)
(r=0.87, p<0.0001) and question 4 (how often have hard stools in last 3 months) (r=0.85,
p <0.0001)

Multivariate analysis as seen in table 7, indicated that question 4 (how often have hard lumpy
stools) was the only statistically significant predictor of constipation. Those with a high score for

question 4 were 2.72 times more likely to be constipated (95% CI 1.02-7.27)

DISCUSSION
The aim of this study was to describe the bowel habits of people with CKD using three
different methods. This study found that constipation was common. Regardless of what tool
was used there were no differences in the prevalence of constipation between either of the
three groups. This differs from other studies where the prevalence of constipation was found
to be higher in patients receiving HD using Rome III criteria (Zhang et al 2013:) and in both
HD and PD patients compared to those not on dialysis using Rome II criteria (Cano et al
2007). Interestingly in our study, HD patients had highest prevalence of constipation using
BSFS not Rome criteria, the reason for this is not clear.
In this study the significant finding was that the prevalence of constipation differed markedly
depending on the tool used and that prevalence of constipation was highest when assessed
7

by self-perception. This is in line with other literature where self-reporting and perception of
constipation is high and possibly over reported (Jones et al 2002; Wu et al 2004; Garrigues et
al 2004; Lee 2011, Dong et al 2014). Clearly relying on perception alone will not give a clear
indication of whether or not the patient is constipated, and this can make patient assessment
difficult.
Despite many patients reporting constipation, the surprising finding was that laxative use in
all three groups was minimal. Increased laxative use has been reported in both HD and PD
patients (Cano et al 2007; Sutton et al 2014) therefore the reason for this finding is unclear.
Laxatives are not routinely prescribed to PD or HD patients in this unit. For PD patients in this
unit prescribing of laxatives occurs when constipation is suspected due to a dialysis issue.

There are several limitations to our study. These include the cross sectional nature and small
sample size due to missed recruiting opportunity. However, the strength lies in the fact that
all three tools were completed simultaneously by participants and complete data obtained on
all subjects. Those with poor English language skills were not included due to the nature and
possible sensitivity of the questions. Further research is required on larger sample sizes to
confirm our findings that variations exist in the prevalence of constipation depending on the
tool used.

Application to clinical practice
A bowel management assessment guide was developed as a result of our research findings.
It is envisaged that this will be used to assist in patient management health care staff. It is
also is aimed for use by patients to assist in self managing constipation, particularly to
indicate when laxative use may be beneficial. This assessment guide was developed to
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incorporate questions from the Rome III criteria and the BSFS (see appendix 3) therefore
combining the two tools.
The management guide uses three coloured sections to guide either the patient or nurse as
to the appropriate action required to maintain good bowel function, in particular prompting the
need for laxative use. The green coloured section indicates adequate bowel function, yellow
and orange sections indicate need for laxatives, especially if no laxative is used. Red
sections indicates that laxative use is required and recommended. This patient management
guide aims to be proactive in the management of constipation and is envisaged to be most
useful for PD patients where constipation can actually affect the dialysis process. Further
research is required to assess its usefulness and practicality in clinical practice.

Conclusion
The results of our study indicate that constipation is a common problem, and in our study was
not predominated by one type of renal replacement modality. Results from our study indicate
that no single method alone is sufficient for accurately determining if a patient is constipated.
The common method used by health professionals of relying on the patients’ self-perception
may give an overestimation of the problem. Ideally patient assessment of constipation
should incorporate both the Rome III criteria and BSFS in a method such as the one that has
been designed as a result of this research. Further research will be required to assess its
usability and practicality in clinical practice.
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Table 1 Demographics
Participant
Demographics
Mean age in years
(SD)
Years on dialysis ( SD)
Gender, n males (%)
Diabetes, n (%)
Laxative use ^, n (%)
No laxatives, n (%)
Docusate
Docusate and senna
PEG
Other

HD
(n=98)
66.6 (13.6)

PD
(n=21)
69.1 (15.6)

PRE
(n=21)
64.2 (13.5)

Total
(n=140)
66.6 (13.9)

P value

8.45 (7.7)
59 (60.2)
38 (38.8)
30 (30.6)
65 (66.3)
2 (2.0)
12 (12.2)
5 (5.1)
7 (7.1)

5.32 (2.6)
13 (61.9)
9 (42.9)
9 (42.9)
12 (57.1)
2 (9.5)
3 (14.3)
1 (4.8)
2 (9.5)

N/A
10 (47.6)
8 (38.1)
5 (23.8)
16 (76.1)
1 (4.8)
0 (0)
2 (9.5)
2 (9.5)

6.71 (6.45)
82 (58.6)
55 (39.3)
44 (31.4)
107 (76.4)
5(3.6)
15 (10.7)
8 (5.7)
11 (7.9)

0.001
0.54
0.94
0.39
0.39

0.52

HD: Haemodialysis; PD: Peritoneal Dialysis; PRE: pre dialysis

^ indicates use of at least 1 laxative
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Table 2 Primary Cause Renal Failure
HD
(n=98)

PD
(n=21)

PRE
(n=21)

Total
(n=140)

Diabetic Nephropathy

28

4

6

38

Glomerular Nephritis

14

2

1

17

Hypertension

3

4

3

10

Polycystic Kidney Disease

3

0

5

8

Reflux Nephropathy

6

2

0

8

Analgesic Nephropathy

3

2

0

5

Renal Cell Carcinoma

5

0

0

5

Other

25

3

6

34

Uncertain

11

4

0

15

HD: Haemodialysis; PD: Peritoneal Dialysis; PRE: pre dialysis
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Table 3. Laxatives Used

Laxative use#, n (%)
Most common laxative
n (%)

HD
(n=98)
30 (30.6)
Docusate (18

PD
(n=21)
9 (42.9)
Docusate &

PRE
(n=21)
5 (23.8)
Polyethyle

%)

Senna (22%)

ne glycol

Total
(n=140)
44 (31.4)

(5%)
Polyethyle
ne glycol &
Wheat
dextrin
(5%)
Docusate
(5%)
Sennoside
s (5%)
Senna (5%)
Next most common
laxative n (%)

Polyethylene
glycol (7%)

Polyethylene
glycol (11%)

# represents participants who consumed at least one laxative

HD: Haemodialysis; PD: Peritoneal Dialysis; PRE: Predialysis
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Table 4. Prevalence of constipation
HD
PD
(n=98)
(n=21)
13 (13.5) 3 (14.3)

PRE
(n=21)
1 (4.8)

Total
P value
(n=140)
17 (12.3) 0.52

28 (28.6) 4 (19.0)

4 (19.0)

36 (25.7) 0.50

Using self-perception, n (%)

41 (43.6) 9 (42.9)

13 (61.9) 63 (46.3) 0.30

P value

<0.0001

Functional constipation using
Rome III total score, n (%)
Using BSF, n (%)

0.02

0.005

<0.0001

-

HD: Haemodialysis; PD: Peritoneal Dialysis; PRE: pre dialysis
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Table 5. Sensitivity/ Specificity and Diagnostic Accuracy of relevant variables

Q1 asking / patient
perception
Q2 how regular open
bowels
Q2 and Q4 combined

Sensitivity
(%)
72.7

Specificity
(%)
63.0

Kappa
value
0.28

Kappa
P value
0.07

AUC (95% CI)
0.68 (0.56-0.78)

16.7

96.1

0.17

0.08

0.56 (0.45-0.68)

91.7

43.3

0.23

0.05

0.68 (0.58-0.77)

Q3 do you strain

91.7

46.2

0.26

0.06

0.69 (0.60-0.78)

Q4 are the stools hard or
lumpy score
Q3 and Q4

91.7

45.6

0.25

0.06

0.81 (0.73-0.90)

94.4

32.7

0.17

0.04

0.64 (0.54-0.73)

Q5 incomplete
evacuation score
Q6 sensation can’t pass
stool score
Q7 manual evacuation

80.6

50.0

0.22

0.06

0.69 (0.6-0.79)

74.3

67.0

0.33

0.08

0.70 (0.6-0.8)

40.0

84.6

0.26

0.09

0.63 (0.52-0.75)

Q9 do you take a
laxative
Rome III total score > 10

78.8

55.6

0.33

0.09

0.67 (0.56-0.78)

94.2

31.4

0.31

0.09

0.88 (0.72-0.89)
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Table 6. Factors Associated with Constipation

Age

R value
0.13

P value
0.13

Dialysis vintage

0.10

0.24

Q3 score how often do you open your bowels in last 3 months

0.90

<0.0001

Q 4 score how often have hard stools in last 3 months

0.85

<0.0001

Q5 score how often had feeling of incomplete evacuation in last 3
months
Q6 score how often in last 3 months had sensation of stool that
could not be passed
Q7 score how often in last 3 months manually evacuate stool

0.79

<0.0001

0.87

<0.0001

0.72

<0.0001
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Table 7. Multivariate predictors of constipation
B
Q 2 less than 3 times week
Q 3 score >2
Q4 score
Taking any laxative
Total score Rome III

2.03
1.42
1.00
1.17
-0.11

P value
0.11
0.28
0.04
0.07
0.58

Odds Ratio
7.62
4.14
2.72
3.22
0.61

95% CI
0.64-91.31
0.31-55.54
1.02-7.27
0.90-11.49
0.46-10.99
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Appendix 1.Participant survey
1. In the last 3 months have you suffered from constipation?
0
5
never
rarely
sometimes
often
2.In the last 3 months how often do you
Daily
generally have a bowel movement
every 2nd day
fewer than 3 bowel movements /week
3. In the last 3 months how often do you
Never/ rarely
strain during bowel movements?
Sometimes
Often
Most of the time
Always
4. In the last 3 months how often do you have Never/ rarely
hard or lumpy stools?
Sometimes
Often
Most of the time
Always
5. In the last 3 months how often do you have Never/ rarely
a feeling of incomplete emptying after bowel Sometimes
movement?
Often
Most of the time
Always
6. In the last 3 months how often did you
Never/ rarely
have a sensation that the stool could not be
Sometimes
passed when having a bowel movement?
Often
Most of the time
Always
7. In the last 3 months how often did you
Never/ rarely
press on or around your bottom or remove
Sometimes
stool in order to complete a bowel
Often
movement?
Most of the time
Always
8. In the past 3 months using the Bristol Stool 1 2
3
4
5
6
7
Form Scale identify your usual stool form
type
9. Do you take laxatives
YES
NO
10.If you are taking laxatives please list what
type and how often you require them

10
always
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Appendix 2. Bowel Management Assessment Chart
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